Name: Europe Brain Implants Market Forecast to 2030
SKU: BMIRE00029810
Availability: InStock

Europe Brain Implants Market Forecast to 2030

Europe Brain Implants Market Forecast to 2030 – Regional Analysis – by Treatment [Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulator, Invasive and Non-Invasive Brain-Computer Interface, Responsive Neurostimulation for Seizures, Auditory Brainstem Implant (Retrocochlear Hearing Impairment and Cochlear Hearing Impairment), and Ophthalmic Aid/Implant], Application [Chronic Pain, Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Essential Tremor, Depression, Dystonia, Amyotrophic Lateral Sclerosis (ALS), and Neurofibromatosis 2], and End User (Hospitals and Specialized Clinics/Neurological Centers)

Send Enquiry

Item ID: BMIRE00029810 Category: Library Tag: Medical Devices; number of pages: 103; published: Sep-24

$2,485 – $3,885

Description

The Europe brain implants market was valued at US$ 2,133.30 million in 2022 and is expected to reach US$ 5,162.17 million by 2030; it is estimated to grow at a CAGR of 11.7% from 2022 to 20 30.

Rising Number of Spinal Cord Injuries Fuels the Europe Brain Implants Market

As per the Spinal Injuries Association, ~2,500 people sustain an SCI annually in the UK, and ~50,000 persons are living with an SCI in the country. SCI can lead to severe locomotor deficits or even complete leg paralysis. Spinal cord stimulation is one of the most preferred techniques employed to treat such situations. According to the article “Epidemiology of traumatic spinal cord injuries: a large population-based study,” published in April 2022, the overall age–sex-standardized incidence rate of traumatic spinal cord injuries was 26.5 per 1 million population, and the rates were directly related to age in both the genders. Moreover, the incidence rate of traumatic spinal cord injuries is 59.2 per 1 million and 23.3 per 1 million in males and females, respectively, in people aged 65 and above. Spinal cord stimulators are implantable devices that help block pain signals sent from the brain. Therefore, increasing cases of spinal cord injuries fuel the demand for spinal cord stimulators, which in turn drives the growth of the brain implants market.

Europe Brain Implants Market Overview

The European brain implants market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The factors driving the market growth include Key factors driving the market growth are surging prevalence of neurological disorders with increasing geriatric population and rising number of spinal cords injuries. However, high cost associated with brain implant devices and procedures hinders the market growth. According to a study published at Charité—Universitätsmedizin Berlin, titled “Deep brain stimulation for Parkinson’s disease: new algorithm for the adjustment of stimulation settings developed,” published in 2022, Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s. ~400,000 people were affected by the disease in Germany, and the numbers are increasing due to demographic aging. A growing number of people, including younger people, suffer from neurodegenerative diseases. As per DZNE, German Center for Neurodegenerative Diseases, over 2 million people have dementia or PD in the country. Brain implants have emerged as a potential treatment for PD. These implants, also known as deep brain stimulation (DBS), involve the surgical placement of electrodes in specific areas of the brain.

Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Million)

Europe Brain Implants Market Segmentation

The Europe brain implants market is segmented into treatment, application, end user, and country.

Based on treatment, the Europe brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain–computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held the largest share in 2022. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment.

In terms of application, the Europe brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.

Based on end user, the Europe brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.

Based on country, the Europe brain implants market is segmented the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe brain implants market in 2022.

Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, NeuroSky Inc, ONWARD Medical NV, and Renishaw Plc are some of the leading companies operating in the Europe brain implants market.

Summary Info

Industry:	Medical Devices
Pricing options:	Single User License, Site License, Enterprise License
Geographical coverage:	Europe
Year of Publication:	2024

At 11.7% CAGR, the Europe Brain Implants Market is Speculated to be Worth US$ 5,162.17 million by 2030, Says the Research Team

According to the Research Team’ research, the Europe brain implants market was valued at US$ 2,133.30 million in 2022 and is expected to reach US$ 5,162.17 million by 2030, registering a CAGR of 11.7% from 2022 to 2030. Strategic initiatives by companies and rising number of spinal cord injuries are among the critical factors attributed to the Europe brain implants market expansion.

Companies operating in the brain implants market constantly focus on strategic developments such as product approvals, collaborations, expansions, agreements, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the brain implants market are mentioned below: In December 2022, Abbott launched the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable SCS system available on the market for the treatment of chronic pain. The company’s portfolio of neuromodulation devices also includes Proclaim XR, the recharge-free SCS system, and Proclaim Plus featuring FlexBurst360. In September 2020, Boston Scientific launched its WaveWriter Alpha portfolio of spinal cord stimulator (SCS) systems in Europe, along with additional customization options. SCS therapies provide pain relief by transmitting mild electric current pulses to the spinal cord to disrupt pain signals traversing to the brain. The WaveWriter Alpha SCS systems are indicated as an aid to manage chronic intractable pain.

Brain implant manufacturers are taking steps to expand their operations around the world and launch their products in different regions, which is expected to boost the market penetration and accessibility of their offerings. Therefore, product introduction and strategic moves such as approvals, expansions, and acquisitions create significant growth opportunities in the brain implants market.

On the contrary, high cost associated with brain implant devices and procedures hampers the growth Europe brain implants market.

Based on treatment, the Europe brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held 37.7% share of the Europe brain implants market in 2022, amassing US$ 804.13 million. It is projected to garner US$ 1,336.63 million by 2030 to expand at 6.6% CAGR during 2022-2030. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment.

Based on application, the Europe brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held 37.8% share of the Europe brain implants market in 2022, amassing US$ 806.12 million. It is projected to garner US$ 1,873.32 million by 2030 to expand at 11.1% CAGR during 2022-2030.

Based on end user, the Europe brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held 71.9% share of the Europe brain implants market in 2022, amassing US$ 1,534.56 million. It is projected to garner US$ 3,925.84 million by 2030 to expand at 12.5% CAGR during 2022-2030

Based on country, the Europe brain implants market is categorized into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany held 26.6% share of Europe brain implants market in 2022, amassing US$ 567.63 million. It is projected to garner US$ 1,412.35 million by 2030 to expand at 12.1% CAGR during 2022-2030.

Key players operating in the Europe brain implants market are Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, NeuroSky Inc, ONWARD Medical NV, Renishaw Plc, and CorTec GmbH, among others.

In June 2023; Boston Scientific Corp received US Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems. It provides clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease or essential tremor.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe brain implants market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe brain implants market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and, distribution.

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Brain Implants Market Landscape
4.1 Overview
5. Europe Brain Implants Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
5.1.2 Rising Number of Spinal Cord Injuries
5.2 Key Market Restraints
5.2.1 High Cost Associated with Brain Implant Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Key Future Trends
5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
5.5 Impact Analysis:
6. Brain Implants Market – Europe Market Analysis
6.1 Overview
6.2 Europe Brain Implants Market Revenue (US$ Mn), 2022 – 2030
7. Europe Brain Implants Market – Revenue and Forecast to 2030 – by Treatment.
7.1 Overview
7.2 Europe Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Deep Brain Stimulation
7.3.1 Overview
7.3.2 Deep Brain Stimulation: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Spinal Cord Stimulation
7.4.1 Overview
7.4.2 Spinal Cord Stimulation: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Vagus Nerve Stimulator
7.5.1 Overview
7.5.2 Vagus Nerve Stimulator: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Invasive and Non-Invasive Brain-Computer Interfaces
7.6.1 Overview
7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Responsive Neurostimulation for Seizures
7.7.1 Overview
7.7.2 Responsive Neurostimulation for Seizures: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Auditory Brainstem Implant
7.8.1 Overview
7.8.2 Auditory Brainstem Implant: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8.2.1 Retrocochlear Hearing Impairment
7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.8.2.2 Cochlear Hearing Impairment
7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.9 Ophthalmic Aids/Implant
7.9.1 Overview
7.9.2 Ophthalmic Aids/Implant: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Brain Implants Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Europe Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Chronic Pain
8.3.1 Overview
8.3.2 Chronic Pain: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Parkinson’s disease
8.4.1 Overview
8.4.2 Parkinson’s disease: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer’s disease
8.5.1 Overview
8.5.2 Alzheimer’s disease: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Epilepsy
8.6.1 Overview
8.6.2 Epilepsy: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Essential Tremor
8.7.1 Overview
8.7.2 Essential Tremor: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Amyotrophic Lateral Sclerosis
8.10.1 Overview
8.10.2 Amyotrophic Lateral Sclerosis (ALS): Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Neurofibromatosis 2
8.11.1 Overview
8.11.2 Neurofibromatosis 2: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Brain Implants Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Europe Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Specialized Clinics / Neurological Centers
9.4.1 Overview
9.4.2 Specialized Clinics / Neurological Centers: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Brain Implants Market – Country Analysis
10.1 Europe Brain Implants Market, by Key Country- Revenue, (2022) (US$ Million)
10.1.1 Europe Brain Implants Market, by Country
10.1.1.1 UK
10.1.1.1.1 UK: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 UK: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.1.2.1 UK: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.1.3 UK: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 UK: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.2 Germany
10.1.1.2.1 Germany: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Germany: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.2.1 Germany: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.2.3 Germany: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4 Germany: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 France
10.1.1.3.1 France: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 France: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.2.1 France: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.3.3 France: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4 France: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.4 Italy
10.1.1.4.1 Italy: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Italy: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.4.2.1 Italy: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.4.3 Italy: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.4 Italy: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.5 Spain
10.1.1.5.1 Spain: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.2 Spain: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.5.2.1 Spain: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.5.3 Spain: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.4 Spain: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Europe
10.1.1.6.1 Rest of Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.2 Rest of Europe: Europe Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.6.2.1 Rest of Europe: Europe Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Europe Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Europe: Europe Brain Implants Market, by End-User, 2020-2030 (US$ Million)
11. Europe Brain Implants Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in Europe Brain Implants Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Renishaw Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 CorTec GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.6 Aleva Neurotherapeutics SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 SWOT Analysis
12.6.5 Key Developments
12.7 NeuroSky Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 SWOT Analysis
12.7.5 Key Developments
12.8 ONWARD Medical NV
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Brain Implants Market Segmentation
Table 2. UK: Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 3. UK: Europe Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany: Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany: Europe Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany: Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 10. France: Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 11. France: Europe Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 12. France: Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. France: Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Italy: Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy: Europe Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy: Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy: Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Spain: Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain: Europe Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain: Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain: Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Organic Growth Strategies in Europe Brain Implants Market
Table 27. Recent Inorganic Growth Strategies in the Europe Brain Implants Market
Table 28. Glossary of Terms, Europe Brain Implants Market

LIST OF FIGURES

Figure 1. Europe Brain Implants Market Segmentation, By Country
Figure 2. Europe Brain Implants Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Brain Implants Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 6. Deep Brain Stimulation: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Spinal Cord Stimulation: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Vagus Nerve Stimulator: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Invasive and Non-Invasive Brain-Computer Interfaces: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Responsive Neurostimulation for Seizures: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Auditory Brainstem Implant: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Retrocochlear hearing impairment: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cochlear hearing impairment: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Ophthalmic Aids/Implant: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Chronic Pain: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parkinson’s disease: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Alzheimer’s disease: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Essential Tremor: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Depression: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Dystonia: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Amyotrophic Lateral Sclerosis (ALS): Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Neurofibromatosis 2: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Brain Implants Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 26. Hospitals: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Specialized Clinics / Neurological Centers: Europe Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Europe Brain Implants Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 29. Europe Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 30. UK: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Germany: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. France: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Italy: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Spain: Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Rest of Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Growth Strategies in Europe Brain Implants Market

The List of Companies – Europe Brain Implants Market

1. Abbott Laboratories
2. Aleva Neurotherapeutics SA
3. Boston Scientific Corp
4. Medtronic Plc
5. NeuroSky Inc
6. ONWARD Medical NV
7. Renishaw Plc
8. CorTec GmbH

Reviews

There are no reviews yet.

Be the first to review “Europe Brain Implants Market Forecast to 2030”

You must be logged in to post a review.